https://www.has-sante.fr/portail/jcms/c_2768605/fr/parsabiv-etelcalcetide-agent-anti-parathyroidien 2017 false false false France French English treatment outcome hyperparathyroidism, secondary adult injections, intravenous hemodialysis calcimimetic agents calcimimetic agents parathyroid hormone renal insufficiency, chronic peptides peptides etelcalcetide guidelines for drug use evaluation of the transparency committee Hyperparathyroidism due to renal insufficiency (disorder) comparative effectiveness research etelcalcetide etelcalcetide renal dialysis etelcalcetide hydrochloride etelcalcetide hydrochloride
--- https://www.ema.europa.eu/medicines/human/EPAR/Parsabiv 2016 false false false United Kingdom French English syndication feed summary of product characteristics package leaflet drug evaluation drug approval europe treatment outcome hyperparathyroidism, secondary adult injections, intravenous hemodialysis calcimimetic agents calcimimetic agents parathyroid hormone drug interactions pregnancy breast feeding product surveillance, postmarketing renal insufficiency, chronic peptides peptides drug evaluation, preclinical etelcalcetide etelcalcetide etelcalcetide renal dialysis etelcalcetide hydrochloride etelcalcetide hydrochloride